{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T08:44:28Z","timestamp":1783154668500,"version":"3.54.6"},"reference-count":85,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Diab Rep"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1007\/s11892-019-1277-4","type":"journal-article","created":{"date-parts":[[2019,11,20]],"date-time":"2019-11-20T17:03:52Z","timestamp":1574269432000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":42,"title":["Glycemic Management in the Operating Room: Screening, Monitoring, Oral Hypoglycemics, and Insulin Therapy"],"prefix":"10.1007","volume":"19","author":[{"given":"Elizabeth","family":"Duggan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"York","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,11,20]]},"reference":[{"issue":"8","key":"1277_CR1","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.2337\/dc10-0304","volume":"33","author":"A Frisch","year":"2010","unstructured":"Frisch A, Chandra P, Smiley D, Peng L, Rizzo M, Gatcliffe C, et al. Prevalence and clinical outcome of hyperglycemia in the perioperative period in noncardiac surgery. Diabetes Care. 2010;33(8):1783\u20138.","journal-title":"Diabetes Care"},{"issue":"4","key":"1277_CR2","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1016\/j.jvs.2018.06.212","volume":"69","author":"CA Long","year":"2019","unstructured":"Long CA, Fang ZB, Hu FY, Arya S, Brewster LP, Duggan E, et al. Poor glycemic control is a strong predictor of postoperative morbidity and mortality in patients undergoing vascular surgery. J Vasc Surg. 2019;69(4):1219\u201326.","journal-title":"J Vasc Surg"},{"issue":"5","key":"1277_CR3","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1067\/mtc.2003.181","volume":"125","author":"AP Furnary","year":"2003","unstructured":"Furnary AP, Gao G, Grunkemeier GL, Wu Y, Zerr KJ, Bookin SO, et al. Continuous insulin infusion reduces mortality in patients with diabetes undergoing coronary artery bypass grafting. J Thorac Cardiovasc Surg. 2003;125(5):1007\u201321.","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"1","key":"1277_CR4","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1097\/SLA.0000000000000688","volume":"261","author":"M Kotagal","year":"2015","unstructured":"\u2022 Kotagal M, Symons RG, Hirsch IB, Umpierrez GE, Dellinger EP, Farrokhi ET, et al. Perioperative hyperglycemia and risk of adverse events among patients with and without diabetes. Ann Surg. 2015;261(1):97\u2013103 Surgical outcome database an evaluation of surgical demonstrating that hyperglycemia in non-diabetic patients is significantly associated with poor outcomes.","journal-title":"Ann Surg"},{"issue":"3","key":"1277_CR5","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1210\/jcem.87.3.8341","volume":"87","author":"GE Umpierrez","year":"2002","unstructured":"Umpierrez GE, Isaacs SD, Bazargan N, You X, Thaler LM, Kitabchi AE. Hyperglycemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes. J Clin Endocrinol Metab. 2002;87(3):978\u201382.","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"1277_CR6","doi-asserted-by":"crossref","first-page":"782","DOI":"10.2337\/dc17-2232","volume":"41","author":"W van den Boom","year":"2018","unstructured":"\u2022\u2022 van den Boom W, Schroeder RA, Manning MW, Setji TL, Fiestan GO, Dunson DB. Effect of A1C and glucose on postoperative mortality in noncardiac and cardiac surgeries. Diabetes Care. 2018;41(4):782\u20138 Retrospective analysis of > 13,000 cardiac and non-cardiac surgical patients demonstrating that when blood glucose is controlled for, A1C may not be associated linearly with 30-day mortality.","journal-title":"Diabetes Care"},{"issue":"4","key":"1277_CR7","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/j.jamcollsurg.2015.07.013","volume":"221","author":"CJ Goodenough","year":"2015","unstructured":"Goodenough CJ, Liang MK, Nguyen MT, Nguyen DH, Holihan JL, Alawadi ZM, et al. Preoperative glycosylated hemoglobin and postoperative glucose together predict major complications after abdominal surgery. J Am Coll Surg. 2015;221(4):854\u201361 e1.","journal-title":"J Am Coll Surg"},{"issue":"9 Suppl","key":"1277_CR8","doi-asserted-by":"crossref","first-page":"S508","DOI":"10.1097\/01.CCM.0000278047.06965.20","volume":"35","author":"E Barth","year":"2007","unstructured":"Barth E, Albuszies G, Baumgart K, Matejovic M, Wachter U, Vogt J, et al. Glucose metabolism and catecholamines. Crit Care Med. 2007;35(9 Suppl):S508\u201318.","journal-title":"Crit Care Med"},{"issue":"9677","key":"1277_CR9","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1016\/S0140-6736(09)60553-5","volume":"373","author":"KM Dungan","year":"2009","unstructured":"Dungan KM, Braithwaite SS, Preiser JC. Stress hyperglycaemia. Lancet. 2009;373(9677):1798\u2013807.","journal-title":"Lancet."},{"issue":"2","key":"1277_CR10","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1172\/JCI5001","volume":"103","author":"A Dresner","year":"1999","unstructured":"Dresner A, Laurent D, Marcucci M, Griffin ME, Dufour S, Cline GW, et al. Effects of free fatty acids on glucose transport and IRS-1-associated phosphatidylinositol 3-kinase activity. J Clin Invest. 1999;103(2):253\u20139.","journal-title":"J Clin Invest"},{"issue":"11","key":"1277_CR11","doi-asserted-by":"crossref","first-page":"4854","DOI":"10.1073\/pnas.91.11.4854","volume":"91","author":"GS Hotamisligil","year":"1994","unstructured":"Hotamisligil GS, Murray DL, Choy LN, Spiegelman BM. Tumor necrosis factor alpha inhibits signaling from the insulin receptor. Proc Natl Acad Sci U S A. 1994;91(11):4854\u20138.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"Supplement 1","key":"1277_CR12","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.2337\/db18-1305-P","volume":"67","author":"ELIZABETH W. DUGGAN","year":"2018","unstructured":"Duggan EW, O'Reilly-Shah VN, Tsegka KG, Galindo RJ, Umpierrez GE. HbA1c screening characterizes undiagnosed dysglycemia in surgical patients. Diabetes. 2018;67(Supplement 1). https:\/\/doi.org\/10.2337\/db18-1305-P.","journal-title":"Diabetes"},{"issue":"1","key":"1277_CR13","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/SLA.0b013e31827b6bbc","volume":"257","author":"S Kwon","year":"2013","unstructured":"Kwon S, Thompson R, Dellinger P, Yanez D, Farrohki E, Flum D. Importance of perioperative glycemic control in general surgery: a report from the Surgical Care and Outcomes Assessment Program. Ann Surg. 2013;257(1):8\u201314.","journal-title":"Ann Surg"},{"issue":"4","key":"1277_CR14","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.2337\/diacare.26.4.1064","volume":"26","author":"LS Greci","year":"2003","unstructured":"Greci LS, Kailasam M, Malkani S, Katz DL, Hulinsky I, Ahmadi R, et al. Utility of HbA(1c) levels for diabetes case finding in hospitalized patients with hyperglycemia. Diabetes Care. 2003;26(4):1064\u20138.","journal-title":"Diabetes Care"},{"key":"1277_CR15","unstructured":"Diabetes 2017 Report Card: US Dept of Health and Human Services; 2018 [Available from: https:\/\/www.cdc.gov\/diabetes\/pdfs\/library\/diabetesreportcard2017-508.pdf."},{"key":"1277_CR16","doi-asserted-by":"crossref","unstructured":"\u2022\u2022 American Diabetes A. 15. Diabetes care in the hospital: standards of medical care in diabetes-2019. Diabetes care. 2019;42(Suppl 1):S173-S81. Current recommendations from the ADA regarding testing and treatment of hospitalized diabetic patients.","DOI":"10.2337\/dc19-S008"},{"key":"1277_CR17","doi-asserted-by":"crossref","unstructured":"\u2022\u2022 American Diabetes A. 2. Classification and diagnosis of diabetes: standards of medical care in diabetes-2019. Diabetes care. 2019;42(Suppl 1):S13-S28. Updated standards for screening\/testing for abnormal glucose tolerance and diabetes.","DOI":"10.2337\/dc19-S002"},{"issue":"4","key":"1277_CR18","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1001\/archsurg.141.4.375","volume":"141","author":"AS Dronge","year":"2006","unstructured":"Dronge AS, Perkal MF, Kancir S, Concato J, Aslan M, Rosenthal RA. Long-term glycemic control and postoperative infectious complications. Arch Surg. 2006;141(4):375\u201380 discussion 80.","journal-title":"Arch Surg"},{"issue":"6","key":"1277_CR19","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.2337\/dc17-2304","volume":"41","author":"PH Yong","year":"2018","unstructured":"\u2022\u2022 Yong PH, Weinberg L, Torkamani N, Churilov L, Robbins RJ, Ma R, et al. The presence of diabetes and higher HbA1c are independently associated with adverse outcomes after surgery. Diabetes care. 2018;41(6):1172\u20139 Prospective, observation study which screened 7,655 inpatients with A1C, demonstrating diabetes was associated with 6-month mortality and increaseing A1C associated with major complications, ICU admission and hospital LOS.","journal-title":"Diabetes care"},{"issue":"6","key":"1277_CR20","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1213\/ANE.0b013e3181f9c288","volume":"111","author":"GP Joshi","year":"2010","unstructured":"Joshi GP, Chung F, Vann MA, Ahmad S, Gan TJ, Goulson DT, et al. Society for Ambulatory Anesthesia consensus statement on perioperative blood glucose management in diabetic patients undergoing ambulatory surgery. Anesth Analg. 2010;111(6):1378\u201387.","journal-title":"Anesth Analg"},{"issue":"6","key":"1277_CR21","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.jclinane.2014.02.001","volume":"26","author":"A Gottschalk","year":"2014","unstructured":"Gottschalk A, Rink B, Smektala R, Piontek A, Ellger B, Gottschalk A. Spinal anesthesia protects against perioperative hyperglycemia in patients undergoing hip arthroplasty. J Clin Anesth. 2014;26(6):455\u201360.","journal-title":"J Clin Anesth"},{"issue":"13","key":"1277_CR22","doi-asserted-by":"crossref","first-page":"e6451","DOI":"10.1097\/MD.0000000000006451","volume":"96","author":"X Li","year":"2017","unstructured":"Li X, Wang J, Chen K, Li Y, Wang H, Mu Y, et al. Effect of different types of anesthesia on intraoperative blood glucose of diabetic patients: a PRISMA-compliant systematic review and meta-analysis. Medicine (Baltimore). 2017;96(13):e6451.","journal-title":"Medicine (Baltimore)"},{"issue":"2","key":"1277_CR23","doi-asserted-by":"crossref","first-page":"91","DOI":"10.5152\/TJAR.2014.49092","volume":"43","author":"D Acar","year":"2015","unstructured":"Acar D, Erkilic EK, Gumus T, Sahin D, Dincel AS, Kanbak O. The effects of different anaesthetic techniques on surgical stress response during inguinal hernia operations. Turk J Anaesthesiol Reanim. 2015;43(2):91\u20139.","journal-title":"Turk J Anaesthesiol Reanim"},{"issue":"5","key":"1277_CR24","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1213\/ANE.0b013e3181b8554a","volume":"109","author":"T Kitamura","year":"2009","unstructured":"Kitamura T, Ogawa M, Kawamura G, Sato K, Yamada Y. The effects of sevoflurane and propofol on glucose metabolism under aerobic conditions in fed rats. Anesth Analg. 2009;109(5):1479\u201385.","journal-title":"Anesth Analg"},{"issue":"4","key":"1277_CR25","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s00540-005-0341-1","volume":"19","author":"T Tanaka","year":"2005","unstructured":"Tanaka T, Nabatame H, Tanifuji Y. Insulin secretion and glucose utilization are impaired under general anesthesia with sevoflurane as well as isoflurane in a concentration-independent manner. J Anesth. 2005;19(4):277\u201381.","journal-title":"J Anesth"},{"issue":"4","key":"1277_CR26","doi-asserted-by":"crossref","first-page":"e54","DOI":"10.1213\/ANE.0000000000003675","volume":"127","author":"I Gasanova","year":"2018","unstructured":"Gasanova I, Meng J, Minhajuddin A, Melikman E, Alexander JC, Joshi GP. Preoperative continuation versus interruption of oral hypoglycemics in type 2 diabetic patients undergoing ambulatory surgery: a randomized controlled trial. Anesth Analg. 2018;127(4):e54\u2013e6.","journal-title":"Anesth Analg"},{"issue":"3","key":"1277_CR27","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1097\/ALN.0000000000001515","volume":"126","author":"EW Duggan","year":"2017","unstructured":"Duggan EW, Carlson K, Umpierrez GE. Perioperative hyperglycemia management: an update. Anesthesiology. 2017;126(3):547\u201360.","journal-title":"Anesthesiology."},{"key":"1277_CR28","doi-asserted-by":"crossref","unstructured":"American Diabetes A. 9. Pharmacologic approaches to glycemic treatment: standards of medical care in diabetes-2019. Diabetes Care 2019;42(Suppl 1):S90-S102.","DOI":"10.2337\/dc19-S009"},{"issue":"4","key":"1277_CR29","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1111\/j.1464-5491.2012.03582.x","volume":"29","author":"K Dhatariya","year":"2012","unstructured":"Dhatariya K, Levy N, Kilvert A, Watson B, Cousins D, Flanagan D, et al. NHS diabetes guideline for the perioperative management of the adult patient with diabetes. Diabet Med. 2012;29(4):420\u201333.","journal-title":"Diabet Med"},{"key":"1277_CR30","first-page":"CD002967","volume":"1","author":"SR Salpeter","year":"2010","unstructured":"Salpeter SR, Greyber E, Pasternak GA, Salpeter Posthumous EE. Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus. Cochrane Database Syst Rev. 2010;1:CD002967.","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"1277_CR31","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1213\/01.ane.0000242532.42656.e7","volume":"104","author":"AI Duncan","year":"2007","unstructured":"Duncan AI, Koch CG, Xu M, Manlapaz M, Batdorf B, Pitas G, et al. Recent metformin ingestion does not increase in-hospital morbidity or mortality after cardiac surgery. Anesth Analg. 2007;104(1):42\u201350.","journal-title":"Anesth Analg"},{"issue":"1","key":"1277_CR32","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1210\/jc.2011-2098","volume":"97","author":"GE Umpierrez","year":"2012","unstructured":"Umpierrez GE, Hellman R, Korytkowski MT, Kosiborod M, Maynard GA, Montori VM, et al. Management of hyperglycemia in hospitalized patients in non-critical care setting: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2012;97(1):16\u201338.","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"1277_CR33","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.2337\/dc15-1251","volume":"38","author":"N Erondu","year":"2015","unstructured":"Erondu N, Desai M, Ways K, Meininger G. Diabetic ketoacidosis and related events in the canagliflozin type 2 diabetes clinical program. Diabetes Care. 2015;38(9):1680\u20136.","journal-title":"Diabetes Care"},{"issue":"9","key":"1277_CR34","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.2337\/dc15-0843","volume":"38","author":"AL Peters","year":"2015","unstructured":"Peters AL, Buschur EO, Buse JB, Cohan P, Diner JC, Hirsch IB. Euglycemic diabetic ketoacidosis: a potential complication of treatment with sodium-glucose cotransporter 2 inhibition. Diabetes Care. 2015;38(9):1687\u201393.","journal-title":"Diabetes Care"},{"issue":"7","key":"1277_CR35","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/S2213-8587(15)00204-1","volume":"3","author":"J Hine","year":"2015","unstructured":"Hine J, Paterson H, Abrol E, Russell-Jones D, Herring R. SGLT inhibition and euglycaemic diabetic ketoacidosis. Lancet Diabetes Endocrinol. 2015;3(7):503\u20134.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"6","key":"1277_CR36","doi-asserted-by":"crossref","first-page":"753","DOI":"10.4158\/EP161292.PS","volume":"22","author":"Y Handelsman","year":"2016","unstructured":"Handelsman Y, Henry RR, Bloomgarden ZT, Dagogo-Jack S, DeFronzo RA, Einhorn D, et al. American Association of Clinical Endocrinologists and American College of endocrinology position statement on the association of Sglt-2 inhibitors and diabetic ketoacidosis. Endocr Pract. 2016;22(6):753\u201362.","journal-title":"Endocr Pract"},{"issue":"1","key":"1277_CR37","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1089\/pancan.2018.0016","volume":"4","author":"DJ Pace","year":"2018","unstructured":"Pace DJ, Dukleska K, Phillips S, Gleason V, Yeo CJ. Euglycemic diabetic ketoacidosis due to sodium-glucose cotransporter 2 inhibitor use in two patients undergoing pancreatectomy. J Pancreat Cancer. 2018;4(1):95\u20139.","journal-title":"J Pancreat Cancer"},{"issue":"2","key":"1277_CR38","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1161\/CIRCIMAGING.109.899377","volume":"3","author":"PA Read","year":"2010","unstructured":"Read PA, Khan FZ, Heck PM, Hoole SP, Dutka DP. DPP-4 inhibition by sitagliptin improves the myocardial response to dobutamine stress and mitigates stunning in a pilot study of patients with coronary artery disease. Circ Cardiovasc Imaging. 2010;3(2):195\u2013201.","journal-title":"Circ Cardiovasc Imaging"},{"issue":"5","key":"1277_CR39","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1177\/0091270008316885","volume":"48","author":"GC Mistry","year":"2008","unstructured":"Mistry GC, Maes AL, Lasseter KC, Davies MJ, Gottesdiener KM, Wagner JA, et al. Effect of sitagliptin, a dipeptidyl peptidase-4 inhibitor, on blood pressure in nondiabetic patients with mild to moderate hypertension. J Clin Pharmacol. 2008;48(5):592\u20138.","journal-title":"J Clin Pharmacol"},{"issue":"9","key":"1277_CR40","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1007\/s00125-006-0340-2","volume":"49","author":"N Matikainen","year":"2006","unstructured":"Matikainen N, Manttari S, Schweizer A, Ulvestad A, Mills D, Dunning BE, et al. Vildagliptin therapy reduces postprandial intestinal triglyceride-rich lipoprotein particles in patients with type 2 diabetes. Diabetologia. 2006;49(9):2049\u201357.","journal-title":"Diabetologia"},{"issue":"11","key":"1277_CR41","doi-asserted-by":"crossref","first-page":"3430","DOI":"10.2337\/dc13-0277","volume":"36","author":"GE Umpierrez","year":"2013","unstructured":"Umpierrez GE, Gianchandani R, Smiley D, Jacobs S, Wesorick DH, Newton C, et al. Safety and efficacy of sitagliptin therapy for the inpatient management of general medicine and surgery patients with type 2 diabetes: a pilot, randomized, controlled study. Diabetes Care. 2013;36(11):3430\u20135.","journal-title":"Diabetes Care"},{"issue":"3","key":"1277_CR42","doi-asserted-by":"crossref","first-page":"450","DOI":"10.2337\/dc18-1760","volume":"42","author":"M Fayfman","year":"2019","unstructured":"Fayfman M, Galindo RJ, Rubin DJ, Mize DL, Anzola I, Urrutia MA, et al. A randomized controlled trial on the safety and efficacy of exenatide therapy for the inpatient management of general medicine and surgery patients with type 2 diabetes. Diabetes Care. 2019;42(3):450\u20136.","journal-title":"Diabetes Care"},{"issue":"2","key":"1277_CR43","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S2213-8587(16)30402-8","volume":"5","author":"FJ Pasquel","year":"2017","unstructured":"Pasquel FJ, Gianchandani R, Rubin DJ, Dungan KM, Anzola I, Gomez PC, et al. Efficacy of sitagliptin for the hospital management of general medicine and surgery patients with type 2 diabetes (Sita-Hospital): a multicentre, prospective, open-label, non-inferiority randomised trial. Lancet Diabetes Endocrinol. 2017;5(2):125\u201333.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"9","key":"1277_CR44","doi-asserted-by":"crossref","first-page":"271","DOI":"10.3390\/jcm7090271","volume":"7","author":"Luis P\u00e9rez-Belmonte","year":"2018","unstructured":"Perez-Belmonte LM, Gomez-Doblas JJ, Millan-Gomez M, Lopez-Carmona MD, Guijarro-Merino R, Carrasco-Chinchilla F, et al. Use of linagliptin for the management of medicine department inpatients with type 2 diabetes in real-world clinical practice (Lina-Real-World Study). J Clin Med. 2018;7(9).","journal-title":"Journal of Clinical Medicine"},{"issue":"5","key":"1277_CR45","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1097\/ALN.0000000000001838","volume":"127","author":"G Besch","year":"2017","unstructured":"Besch G, Perrotti A, Mauny F, Puyraveau M, Baltres M, Flicoteaux G, et al. Clinical effectiveness of intravenous exenatide infusion in perioperative glycemic control after coronary artery bypass graft surgery: a phase II\/III randomized trial. Anesthesiology. 2017;127(5):775\u201387.","journal-title":"Anesthesiology."},{"issue":"3","key":"1277_CR46","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1111\/anae.14180","volume":"73","author":"JAW Polderman","year":"2018","unstructured":"Polderman JAW, van Steen SCJ, Thiel B, Godfried MB, Houweling PL, Hollmann MW, et al. Peri-operative management of patients with type-2 diabetes mellitus undergoing non-cardiac surgery using liraglutide, glucose-insulin-potassium infusion or intravenous insulin bolus regimens: a randomised controlled trial. Anaesthesia. 2018;73(3):332\u20139.","journal-title":"Anaesthesia."},{"key":"1277_CR47","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.jclinane.2016.10.003","volume":"36","author":"LJ Demma","year":"2017","unstructured":"Demma LJ, Carlson KT, Duggan EW, Morrow JG 3rd, Umpierrez G. Effect of basal insulin dosage on blood glucose concentration in ambulatory surgery patients with type 2 diabetes. J Clin Anesth. 2017;36:184\u20138.","journal-title":"J Clin Anesth"},{"issue":"8","key":"1277_CR48","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.jclinane.2012.02.010","volume":"24","author":"SI Rosenblatt","year":"2012","unstructured":"Rosenblatt SI, Dukatz T, Jahn R, Ramsdell C, Sakharova A, Henry M, et al. Insulin glargine dosing before next-day surgery: comparing three strategies. J Clin Anesth. 2012;24(8):610\u20137.","journal-title":"J Clin Anesth"},{"key":"1277_CR49","unstructured":"Likavec A MV, Greenberg J, Drum M, Sweitzer B. Comparison of preoperative blood glucose levels in patients receiving different insulin regimens. Anesthesiology. 2006;105(567)."},{"issue":"4","key":"1277_CR50","doi-asserted-by":"crossref","first-page":"637","DOI":"10.2337\/dc14-0006","volume":"38","author":"RH Becker","year":"2015","unstructured":"Becker RH, Dahmen R, Bergmann K, Lehmann A, Jax T, Heise T. New insulin glargine 300 units \u00b7 mL-1 provides a more even activity profile and prolonged glycemic control at steady state compared with insulin glargine 100 units \u00b7 mL-1. Diabetes Care. 2015;38(4):637\u201343.","journal-title":"Diabetes Care"},{"issue":"9825","key":"1277_CR51","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1016\/S0140-6736(12)60205-0","volume":"379","author":"AJ Garber","year":"2012","unstructured":"Garber AJ, King AB, Del Prato S, Sreenan S, Balci MK, Munoz-Torres M, et al. Insulin degludec, an ultra-longacting basal insulin, versus insulin glargine in basal-bolus treatment with mealtime insulin aspart in type 2 diabetes (BEGIN Basal-Bolus Type 2): a phase 3, randomised, open-label, treat-to-target non-inferiority trial. Lancet. 2012;379(9825):1498\u2013507.","journal-title":"Lancet."},{"issue":"4","key":"1277_CR52","doi-asserted-by":"crossref","first-page":"353","DOI":"10.4158\/EP09102.RA","volume":"15","author":"ES Moghissi","year":"2009","unstructured":"Moghissi ES, Korytkowski MT, DiNardo M, Einhorn D, Hellman R, Hirsch IB, et al. American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control. Endocr Pract. 2009;15(4):353\u201369.","journal-title":"Endocr Pract"},{"issue":"2","key":"1277_CR53","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.athoracsur.2008.11.011","volume":"87","author":"HL Lazar","year":"2009","unstructured":"Lazar HL, McDonnell M, Chipkin SR, Furnary AP, Engelman RM, Sadhu AR, et al. The Society of Thoracic Surgeons practice guideline series: blood glucose management during adult cardiac surgery. Ann Thorac Surg. 2009;87(2):663\u20139.","journal-title":"Ann Thorac Surg"},{"issue":"12","key":"1277_CR54","doi-asserted-by":"crossref","first-page":"3251","DOI":"10.1097\/CCM.0b013e3182653269","volume":"40","author":"J Jacobi","year":"2012","unstructured":"Jacobi J, Bircher N, Krinsley J, Agus M, Braithwaite SS, Deutschman C, et al. Guidelines for the use of an insulin infusion for the management of hyperglycemia in critically ill patients. Crit Care Med. 2012;40(12):3251\u201376.","journal-title":"Crit Care Med"},{"issue":"9","key":"1277_CR55","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.2337\/dc15-0303","volume":"38","author":"G Umpierrez","year":"2015","unstructured":"Umpierrez G, Cardona S, Pasquel F, Jacobs S, Peng L, Unigwe M, et al. Randomized controlled trial of intensive versus conservative glucose control in patients undergoing coronary artery bypass graft surgery: GLUCO-CABG trial. Diabetes Care. 2015;38(9):1665\u201372.","journal-title":"Diabetes Care"},{"issue":"6","key":"1277_CR56","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1177\/0145721705281563","volume":"31","author":"CB Cook","year":"2005","unstructured":"Cook CB, Boyle ME, Cisar NS, Miller-Cage V, Bourgeois P, Roust LR, et al. Use of continuous subcutaneous insulin infusion (insulin pump) therapy in the hospital setting: proposed guidelines and outcome measures. Diabetes Educ. 2005;31(6):849\u201357.","journal-title":"Diabetes Educ"},{"issue":"10","key":"1277_CR57","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1007\/s11892-017-0919-7","volume":"17","author":"CE Mendez","year":"2017","unstructured":"Mendez CE, Umpierrez GE. Management of type 1 diabetes in the hospital setting. Curr Diab Rep. 2017;17(10):98.","journal-title":"Curr Diab Rep"},{"issue":"8","key":"1277_CR58","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.jclinane.2012.04.009","volume":"24","author":"ES Schwenk","year":"2012","unstructured":"Schwenk ES, Mraovic B, Maxwell RP, Kim GS, Ehrenfeld JM, Epstein RH. Root causes of intraoperative hypoglycemia: a case series. J Clin Anesth. 2012;24(8):625\u201330.","journal-title":"J Clin Anesth"},{"issue":"1","key":"1277_CR59","first-page":"46","volume":"11","author":"S Finfer","year":"2009","unstructured":"Finfer S, Heritier S, Committee NSM, Committee SSE. The NICE-SUGAR (normoglycaemia in intensive care evaluation and survival using glucose algorithm regulation) study: statistical analysis plan. Crit Care Resusc. 2009;11(1):46\u201357.","journal-title":"Crit Care Resusc"},{"issue":"2","key":"1277_CR60","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1097\/ALN.0000000000001466","volume":"126","author":"AJ Toner","year":"2017","unstructured":"Toner AJ, Ganeshanathan V, Chan MT, Ho KM, Corcoran TB. Safety of perioperative glucocorticoids in elective noncardiac surgery: a systematic review and meta-analysis. Anesthesiology. 2017;126(2):234\u201348.","journal-title":"Anesthesiology."},{"issue":"9","key":"1277_CR61","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1111\/anae.13544","volume":"71","author":"M Tien","year":"2016","unstructured":"Tien M, Gan TJ, Dhakal I, White WD, Olufolabi AJ, Fink R, et al. The effect of anti-emetic doses of dexamethasone on postoperative blood glucose levels in non-diabetic and diabetic patients: a prospective randomised controlled study. Anaesthesia. 2016;71(9):1037\u201343.","journal-title":"Anaesthesia."},{"issue":"7","key":"1277_CR62","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.jclinane.2015.07.003","volume":"27","author":"Y Low","year":"2015","unstructured":"Low Y, White WD, Habib AS. Postoperative hyperglycemia after 4- vs 8-10-mg dexamethasone for postoperative nausea and vomiting prophylaxis in patients with type II diabetes mellitus: a retrospective database analysis. J Clin Anesth. 2015;27(7):589\u201394.","journal-title":"J Clin Anesth"},{"issue":"4","key":"1277_CR63","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1517\/14740338.2016.1140743","volume":"15","author":"M Oray","year":"2016","unstructured":"Oray M, Abu Samra K, Ebrahimiadib N, Meese H, Foster CS. Long-term side effects of glucocorticoids. Expert Opin Drug Saf. 2016;15(4):457\u201365.","journal-title":"Expert Opin Drug Saf"},{"issue":"2","key":"1277_CR64","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1093\/bja\/aew446","volume":"118","author":"T Corcoran","year":"2017","unstructured":"Corcoran T, Kasza J, Short TG, O'Loughlin E, Chan MT, Leslie K, et al. Intraoperative dexamethasone does not increase the risk of postoperative wound infection: a propensity score-matched post hoc analysis of the ENIGMA-II trial (EnDEX). Br J Anaesth. 2017;118(2):190\u20139.","journal-title":"Br J Anaesth"},{"key":"1277_CR65","first-page":"CD011770","volume":"11","author":"C Pehora","year":"2017","unstructured":"Pehora C, Pearson AM, Kaushal A, Crawford MW, Johnston B. Dexamethasone as an adjuvant to peripheral nerve block. Cochrane Database Syst Rev. 2017;11:CD011770.","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"1277_CR66","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1093\/bja\/aet109","volume":"111","author":"M Desmet","year":"2013","unstructured":"Desmet M, Braems H, Reynvoet M, Plasschaert S, Van Cauwelaert J, Pottel H, et al. I.V. and perineural dexamethasone are equivalent in increasing the analgesic duration of a single-shot interscalene block with ropivacaine for shoulder surgery: a prospective, randomized, placebo-controlled study. Br J Anaesth. 2013;111(3):445\u201352.","journal-title":"Br J Anaesth"},{"issue":"23","key":"1277_CR67","doi-asserted-by":"crossref","first-page":"e3828","DOI":"10.1097\/MD.0000000000003828","volume":"95","author":"EH Chun","year":"2016","unstructured":"Chun EH, Kim YJ, Woo JH. Which is your choice for prolonging the analgesic duration of single-shot interscalene brachial blocks for arthroscopic shoulder surgery? intravenous dexamethasone 5 mg vs. perineural dexamethasone 5 mg randomized, controlled, clinical trial. Medicine (Baltimore). 2016;95(23):e3828.","journal-title":"Medicine (Baltimore)"},{"issue":"8","key":"1277_CR68","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.2337\/dci18-0002","volume":"41","author":"GE Umpierrez","year":"2018","unstructured":"Umpierrez GE, Klonoff DC. Diabetes technology update: use of insulin pumps and continuous glucose monitoring in the hospital. Diabetes Care. 2018;41(8):1579\u201389.","journal-title":"Diabetes Care"},{"issue":"1","key":"1277_CR69","doi-asserted-by":"crossref","first-page":"24","DOI":"10.4158\/EP.15.1.24","volume":"15","author":"RM Bailon","year":"2009","unstructured":"Bailon RM, Partlow BJ, Miller-Cage V, Boyle ME, Castro JC, Bourgeois PB, et al. Continuous subcutaneous insulin infusion (insulin pump) therapy can be safely used in the hospital in select patients. Endocr Pract. 2009;15(1):24\u20139.","journal-title":"Endocr Pract"},{"issue":"1","key":"1277_CR70","doi-asserted-by":"crossref","first-page":"49","DOI":"10.4158\/EP11157.OR","volume":"18","author":"AA Nassar","year":"2012","unstructured":"Nassar AA, Boyle ME, Seifert KM, Beer KA, Apsey HA, Schlinkert RT, et al. Insulin pump therapy in patients with diabetes undergoing surgery. Endocr Pract. 2012;18(1):49\u201355.","journal-title":"Endocr Pract"},{"issue":"1","key":"1277_CR71","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1177\/193229681200600123","volume":"6","author":"ME Boyle","year":"2012","unstructured":"Boyle ME, Seifert KM, Beer KA, Apsey HA, Nassar AA, Littman SD, et al. Guidelines for application of continuous subcutaneous insulin infusion (insulin pump) therapy in the perioperative period. J Diabetes Sci Technol. 2012;6(1):184\u201390.","journal-title":"J Diabetes Sci Technol"},{"issue":"5","key":"1277_CR72","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1177\/193229681200600503","volume":"6","author":"SM Corney","year":"2012","unstructured":"Corney SM, Dukatz T, Rosenblatt S, Harrison B, Murray R, Sakharova A, et al. Comparison of insulin pump therapy (continuous subcutaneous insulin infusion) to alternative methods for perioperative glycemic management in patients with planned postoperative admissions. J Diabetes Sci Technol. 2012;6(5):1003\u201315.","journal-title":"J Diabetes Sci Technol"},{"issue":"11","key":"1277_CR73","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.4158\/EP15727.OR","volume":"21","author":"SI Sobel","year":"2015","unstructured":"Sobel SI, Augustine M, Donihi AC, Reider J, Forte P, Korytkowski M. Safety and efficacy of a peri-operative protocol for patients with diabetes treated with continuous subcutaneous insulin infusion who are admitted for same-day surgery. Endocr Pract. 2015;21(11):1269\u201376.","journal-title":"Endocr Pract"},{"issue":"5","key":"1277_CR74","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1177\/1932296817706151","volume":"11","author":"A Wallia","year":"2017","unstructured":"Wallia A, Umpierrez GE, Rushakoff RJ, Klonoff DC, Rubin DJ, Hill Golden S, et al. Consensus statement on inpatient use of continuous glucose monitoring. J Diabetes Sci Technol. 2017;11(5):1036\u201344.","journal-title":"J Diabetes Sci Technol"},{"issue":"5","key":"1277_CR75","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1097\/00000539-200111000-00063","volume":"93","author":"J Hausel","year":"2001","unstructured":"Hausel J, Nygren J, Lagerkranser M, Hellstrom PM, Hammarqvist F, Almstrom C, et al. A carbohydrate-rich drink reduces preoperative discomfort in elective surgery patients. Anesth Analg. 2001;93(5):1344\u201350.","journal-title":"Anesth Analg"},{"issue":"3","key":"1277_CR76","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1001\/jamasurg.2016.4952","volume":"152","author":"O Ljungqvist","year":"2017","unstructured":"Ljungqvist O, Scott M, Fearon KC. Enhanced recovery after surgery: a review. JAMA Surg. 2017;152(3):292\u20138.","journal-title":"JAMA Surg."},{"key":"1277_CR77","doi-asserted-by":"crossref","unstructured":"Practice Guidelines for Preoperative Fasting and the Use of Pharmacologic Agents to Reduce the Risk of Pulmonary Aspiration: Application to Healthy Patients Undergoing Elective Procedures: An Updated Report by the American Society of Anesthesiologists Task Force on Preoperative Fasting and the Use of Pharmacologic Agents to Reduce the Risk of Pulmonary Aspiration. Anesthesiology. 2017;126(3):376\u201393.","DOI":"10.1097\/ALN.0000000000001452"},{"issue":"8","key":"1277_CR78","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1097\/EJA.0b013e3283495ba1","volume":"28","author":"I Smith","year":"2011","unstructured":"Smith I, Kranke P, Murat I, Smith A, O'Sullivan G, Soreide E, et al. Perioperative fasting in adults and children: guidelines from the European Society of Anaesthesiology. Eur J Anaesthesiol. 2011;28(8):556\u201369.","journal-title":"Eur J Anaesthesiol"},{"key":"1277_CR79","doi-asserted-by":"crossref","unstructured":"Nelson G, Bakkum-Gamez J, Kalogera E, Glaser G, Altman A, Meyer LA, et al. Guidelines for perioperative care in gynecologic\/oncology: Enhanced Recovery After Surgery (ERAS) Society recommendations-2019 update. Int J Gynecol Cancer. 2019.","DOI":"10.1136\/ijgc-2019-000356"},{"issue":"3","key":"1277_CR80","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1007\/s00268-018-4844-y","volume":"43","author":"UO Gustafsson","year":"2019","unstructured":"Gustafsson UO, Scott MJ, Hubner M, Nygren J, Demartines N, Francis N, et al. Guidelines for perioperative care in elective colorectal surgery: Enhanced Recovery After Surgery (ERAS((R))) Society recommendations: 2018. World J Surg. 2019;43(3):659\u201395.","journal-title":"World J Surg"},{"issue":"1","key":"1277_CR81","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1093\/ejcts\/ezy301","volume":"55","author":"TJP Batchelor","year":"2019","unstructured":"Batchelor TJP, Rasburn NJ, Abdelnour-Berchtold E, Brunelli A, Cerfolio RJ, Gonzalez M, et al. Guidelines for enhanced recovery after lung surgery: recommendations of the Enhanced Recovery After Surgery (ERAS(R)) Society and the European Society of Thoracic Surgeons (ESTS). Eur J Cardiothorac Surg. 2019;55(1):91\u2013115.","journal-title":"Eur J Cardiothorac Surg"},{"key":"1277_CR82","doi-asserted-by":"crossref","unstructured":"Engelman DT, Ben Ali W, Williams JB, Perrault LP, Reddy VS, Arora RC, et al. Guidelines for perioperative care in cardiac surgery: enhanced recovery after surgery society recommendations. JAMA Surg. 2019.","DOI":"10.1001\/jamasurg.2019.1153"},{"key":"1277_CR83","first-page":"CD009161","volume":"8","author":"MD Smith","year":"2014","unstructured":"Smith MD, McCall J, Plank L, Herbison GP, Soop M, Nygren J. Preoperative carbohydrate treatment for enhancing recovery after elective surgery. Cochrane Database Syst Rev. 2014;8:CD009161.","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"1277_CR84","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/bjs.10408","volume":"104","author":"MA Amer","year":"2017","unstructured":"Amer MA, Smith MD, Herbison GP, Plank LD, McCall JL. Network meta-analysis of the effect of preoperative carbohydrate loading on recovery after elective surgery. Br J Surg. 2017;104(3):187\u201397.","journal-title":"Br J Surg"},{"issue":"4","key":"1277_CR85","first-page":"623","volume":"267","author":"L Gianotti","year":"2018","unstructured":"Gianotti L, Biffi R, Sandini M, Marrelli D, Vignali A, Caccialanza R, et al. Preoperative oral carbohydrate load versus placebo in major elective abdominal surgery (PROCY): a randomized, placebo-controlled, multicenter. Phase III Trial Ann Surg. 2018;267(4):623\u201330.","journal-title":"Phase III Trial Ann Surg"}],"container-title":["Current Diabetes Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11892-019-1277-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11892-019-1277-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11892-019-1277-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,6]],"date-time":"2022-10-06T12:51:59Z","timestamp":1665060719000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11892-019-1277-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":85,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["1277"],"URL":"https:\/\/doi.org\/10.1007\/s11892-019-1277-4","relation":{},"ISSN":["1534-4827","1539-0829"],"issn-type":[{"value":"1534-4827","type":"print"},{"value":"1539-0829","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"20 November 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Elizabeth Duggan and York Chen declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}],"article-number":"134"}}